Tiziana Monteverde

I am a member of AstraZeneca’s High-Throughput Screening (HTS) team, where I conduct biochemical and cellular assays to identify novel chemical starting points for the discovery and development of new medicines. As AstraZeneca’s sole HTS function, I collaborate with colleagues across all therapeutic areas, providing screening expertise to support drug discovery programmes from early research through to the identification of promising lead compounds. I use automation extensively to enhance screening capacity, consistency, and efficiency, while continuously evaluating emerging technologies and methodologies that may improve assay performance and accelerate scientific discovery. Through cross-functional collaboration, I establish robust assay cascades to support the effective identification, confirmation, and triaging of screening hits, helping to prioritise compounds with the greatest potential for progression.